Company Filing History:
Years Active: 2019
Title: Thomas Kieckbusch: Innovator in Inhalation Formulations
Introduction
Thomas Kieckbusch is a notable inventor based in Lorrach, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of inhalation therapies. His work focuses on improving the stability and efficacy of inhaled medications.
Latest Patents
Kieckbusch holds a patent for "Compositions of glycopyrronium salt for inhalation." This patent describes a process for preparing dry powder formulations of a glycopyrronium salt that exhibit good stability. The innovative process involves micronizing a glycopyrronium salt with an anti-adherent agent and then admixing carrier particles to create the final dry powder formulation. He has 1 patent to his name.
Career Highlights
Thomas Kieckbusch is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development in the area of inhalation therapies, where he applies his expertise to create effective treatment options for patients.
Collaborations
Throughout his career, Kieckbusch has collaborated with several talented professionals, including Barbara Haeberlin and Frank Stowasser. These collaborations have contributed to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Thomas Kieckbusch's work in the field of inhalation formulations exemplifies the impact of innovation in healthcare. His contributions continue to enhance the effectiveness of treatments available to patients.